Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-3-19
pubmed:abstractText
High vascular pressure targets the lung septal network, causing acute lung injury. While calcium entry in septal endothelium has been implicated, the channel involved is not known. This study tested the hypothesis that the vanilloid transient receptor potential channel, TRPV4, is a critical participant in the permeability response to high vascular pressure. Isolated lungs from TRPV4(+/+) or TRPV4(-/-) mice were studied at baseline or during high pressure challenge. Permeability was assessed via the filtration coefficient. Endothelial calcium transients were assessed using epifluorescence microscopy of the lung subpleural network. Light microscopy and point counting were used to determine the alveolar fluid volume fraction, a measure of alveolar flooding. Baseline permeability, calcium intensity, and alveolar flooding were no different in TRPV4(+/+) versus TRPV4(-/-) lungs. In TRPV4(+/+) lungs, the high pressure-induced permeability response was significantly attenuated by low calcium perfusate, the TRPV antagonist ruthenium red, the phospholipase A(2) inhibitor methyl arachidonyl fluorophosphonate, or the P450 epoxygenase inhibitor propargyloxyphenyl hexanoic acid. Similarly, the high pressure-induced calcium transient in TRPV4(+/+) lungs was attenuated with ruthenium red or the epoxygenase inhibitor. High vascular pressure increased the alveolar fluid volume fraction compared with control. In lungs from TRPV4(-/-) mice, permeability, calcium intensity, and alveolar fluid volume fraction were not increased. These data support a role for P450-derived epoxyeicosatrienoic acid-dependent regulation of calcium entry via TRPV4 in the permeability response to high vascular pressure.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-11081638, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-11160064, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-11943655, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-12354759, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-12538589, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-12702745, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-12738791, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-12765694, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-12879072, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-13458436, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-14578116, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-14581612, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-14691263, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-14707014, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-15909178, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-15987796, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-16179585, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-16382065, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-16675722, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-17008604, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-17085430, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-2055852, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-2272958, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-2732147, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-2759957, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-3996332, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-542024, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-6469784, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-7614719, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-7938920, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-9390969, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-9516173, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-9676631, http://linkedlifedata.com/resource/pubmed/commentcorrection/17962608-9887054
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1535-4989
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
386-92
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
High vascular pressure-induced lung injury requires P450 epoxygenase-dependent activation of TRPV4.
pubmed:affiliation
Department of Physiology, University of South Alabama, 307 University Blvd., Mobile, AL 36688, USA.
pubmed:publicationType
Journal Article, In Vitro, Research Support, N.I.H., Extramural